Peel Therapeutics begins Phase I solid tumour trial
The trial will assess the safety, tolerability, pharmacokinetics and initial antitumor activity of PEEL-224.
Clinical Trials
Latest in
Clinical Trials
MedStar and Georgetown scientists to conduct acute rhinosinusitis trial
The randomised trial will enrol over 3,700 individuals with acute rhinosinusitis.
Back to the future: the evolution of clinical conference topics in the past decade
With the 20th birthday of the renowned Clinical Trial Supply East Coast conference in October, we look at topic changes…
By
Upstream Bio doses first subject in Phase Ib asthma antibody trial
UPB-101 was found to hinder production of cytokine from CD4+ T cells and ILC2, in pre-clinical studies.
BeiGene reports Phase III tislelizumab data in hepatocellular cancer
Tislelizumab’s safety profile was in line with prior trials without any new safety signals observed.
Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study
The trial will analyse the safety, tolerability and pharmacokinetics of various doses of OLX-07010 in healthy elderly subjects.
Saol enrols first subject in Phase II osteoarthritis trial
Efficacy and safety of SL-1002 are the primary endpoints of the trial.
Vial unveils EMR Interface with ModMed to boost trial recruitment
All clinics conducting clinical trials using VialConnect have access to the ModMed interface.